Background:

Human monoclonal neutralizing antibody to COVID-19 S protein

Alternative names:

Spike glycoprotein; S glycoprotein; E2; Peplomer protein

Clonality:

Monoclonal

Species reactivity:

COVID-19

Host:

Human Cells

Immunogen:

Purification method:

>95%, cultured in vitro under conditions free from animal derived components.

Concentration:

1mg/mL

Buffer:

1 mg/ml. Human IgA. Liquid in 0.01M Phosphate Buffered Saline, pH 7.4.

Applications:

E

Recommended dilution:

ELISA: Use at an assay dependent dilution.

Storage:

Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

WB description:

Immobilized Recombinant COVID-19 S Protein RBD-SD1 (Cat#CRP3097) at 5 ug/ml can bind Anti-COVID-19 S-IgA Neutralizing Antibody, the EC50 is less than 416 ng/ml.

IHC description:

Anti-COVID-19 S-IgA Neutralizing Antibody can block Recombinant Human ACE2 Protein (Cat#CRP1003) and Recombinant COVID-19 S Protein RBD-SD1 (Cat#CRP3097) interaction, the IC50 for this effect is 19.8 ng/ml.

IF/ICC description:

N/A

IP description:

N/A

FC description:

N/A

ChIP description:

N/A

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com